National Institute on Aging (NIA): all 160 studies
Page 2 of 2. Open to participants first (13), then studies with results posted, then the rest; newest registration first within each.
- Effect of Vitamin K on Age-Related Bone Loss and Vascular CalcificationCompletedNCT00183001Phase 3
- Alzheimer's Caregiver Communication StudyCompletedNCT00182988
- Effects of Dehydroepiandrosterone (DHEA) in HumansCompletedNCT00182975Phase 3
- GRACE: Geriatric Resources for Assessment and Care of EldersCompletedNCT00182962Not applicable
- Genetics and Epidemiology of Aging Associated Conditions in the Sardinian PopulationCompletedNCT00182949
- A Trial to Reduce Delirium in Aged Post Acute PatientsCompletedNCT00182936Phase 3
- Forearm Vascular RelaxationCompletedNCT00182923
- PACT: Providers and Alzheimer's Caregivers TogetherCompletedNCT00182897Not applicable
- Testosterone Effects on Bone and FrailtyCompletedNCT00182871Phase 4
- Obstructive Sleep Apnea (OSA) and Metabolic Syndrome: Role of Oxidative StressStatus unknownNCT00177892Not applicable
- A Comparison of Weighted Vest Exercise and Strength TrainingCompletedNCT00158119Phase 3
- AFTER: Altering Fat Through Estrogen and RaloxifeneCompletedNCT00149604Phase 2
- The TLC2 (Teaching Healthy Lifestyles to Caregivers 2)/CALM (Counseling Advice for Lifestyle Management) StudyCompletedNCT00131105Phase 2
- The CHAT (Community Health Advice by Telephone) StudyCompletedNCT00131092Phase 2
- Shingles: Immune Effects of Tai ChiCompletedNCT00118885Phase 2
- Anti-Oxidant Treatment of Alzheimer's DiseaseCompletedNCT00117403Phase 1
- The LIFE Study: Lifestyle Interventions and Independence for Elders, PilotCompletedNCT00116194Phase 1/2
- EPAT: Estrogen in the Prevention of Atherosclerosis TrialCompletedNCT00115024Phase 2/3
- BVAIT: B-Vitamin Atherosclerosis Intervention TrialCompletedNCT00114400Phase 2/3
- VEAPS: Vitamin E Atherosclerosis Prevention StudyCompletedNCT00114387Phase 2/3
- Effects of Hormonal Infertility Treatment on Cognition in Pre-Menopausal WomenCompletedNCT00113867
- Biological Effects of Dehydroepiandrosterone (DHEA) in the ElderlyCompletedNCT00111930Not applicable
- Memory Aid for Informed Consent in Alzheimer's ResearchCompletedNCT00105612Not applicable
- Osteoarthritis: Weakness From InflammationCompletedNCT00104312
- Idiopathic Anemia of Aging (IAA)TerminatedNCT00104169Phase 2
- Biologic Effects of Dehydroepiandrosterone (DHEA) in HumansCompletedNCT00099697Not applicable
- Metabolic Syndrome, Inflammation, and Risk of Cognitive DeclineCompletedNCT00099567
- CALERIE (PBRC, Baton Rouge) - Comprehensive Assessment of Long-Term Effects of Reducing Intake of EnergyCompletedNCT00099151Not applicable
- CALERIE (Washington University): Comprehensive Assessment of Long-term Effects of Reducing Intake of EnergyCompletedNCT00099138Phase 1
- CALERIE (Tufts) - Comprehensive Assessment of Long-term Effects of Reducing Intake of EnergyCompletedNCT00099099Phase 1
- Problem Solving/Physical Interventions and AgingCompletedNCT00097643Phase 3
- ABC Trial: Awakening and Breathing ControlledCompletedNCT00097630Not applicable
- Biomarkers and Early Alzheimer's DiseaseStatus unknownNCT00094952
- Predictors of Cognitive Decline in Normal AgingStatus unknownNCT00094939
- PET Changes in Alzheimer's Disease (AD)Status unknownNCT00094913
- SeniorWISE: Improving Everyday Memory in At-Risk ElderlyCompletedNCT00094731Phase 3
- Work and Iron Status EvaluationCompletedNCT00094042Not applicable
- Nicotine Treatment of Mild Cognitive Impairment (MCI)Status unknownNCT00091468Phase 1
- Risk Evaluation and Education for Alzheimer's Disease (REVEAL) IICompletedNCT00089882
- Bryostatin 1 and Rituximab in Treating Patients With B-Cell Non-Hodgkin's Lymphoma or Chronic Lymphocytic LeukemiaCompletedNCT00087425Phase 2
- Huperzine A in Alzheimer's DiseaseCompletedNCT00083590Phase 2
- Obesity Prevention After Smoking Cessation in MenopauseCompletedNCT00064961Not applicable
- Alternative Therapies for Menopause: A Randomized TrialCompletedNCT00061711Not applicable
- A Trial of Tap Water Treatment in the ElderlyCompletedNCT00058942Not applicable
- The HIP Impact Protection Program (HIP PRO)CompletedNCT00058864Not applicable
- VITAL - VITamins to Slow ALzheimer's Disease (Homocysteine Study)CompletedNCT00056225Phase 3
- Cholesterol Lowering Agent to Slow Progression (CLASP) of Alzheimer's Disease StudyCompletedNCT00053599Phase 3
- Treatment of Agitation/Psychosis in Dementia/Parkinsonism (TAP/DAP)CompletedNCT00043849Phase 4
- Healthy Aging and Memory StudyCompletedNCT00034567
- Effectiveness of A Nutritional Brain Metabolic Enhancer for Alzheimer DiseaseCompletedNCT00013923Phase 2
- A Multicenter Trial of Rofecoxib and Naproxen in Alzheimer's Disease (NSAID Study)CompletedNCT00004845Phase 2/3
- Bryostatin 1 and Interleukin-2 in Treating Patients With Refractory Solid Tumors or LymphomaCompletedNCT00003993Phase 1
- AIT-082 Phase 1B StudyCompletedNCT00000180Phase 1
- Agitation in Alzheimer's DiseaseCompletedNCT00000179Phase 3
- Multicenter Trial of Prednisone in Alzheimer's DiseaseCompletedNCT00000178Phase 3
- Estrogen Hormone ProtocolCompletedNCT00000177Phase 3
- Alzheimer's Disease Prevention TrialCompletedNCT00000176Phase 3
- The Effects of Sex Hormones on Cognition and Mood in Older AdultsTerminatedNCT00000175Not applicable
- Memory Impairment Study (Mild Cognitive Impairment Study)CompletedNCT00000173Phase 3
- Study of Melatonin: Sleep Problems in Alzheimer's DiseaseCompletedNCT00000171Phase 3
← National Institute on Aging (NIA) overview and focus areas